First Deuterated Drug Approved
In April, the US Food and Drug Administration cleared the first deuterated drug, Austedo (deutetrabenazine), from Teva of Petach Tikva, Israel, for the treatment of Huntington’sdisease-related movement disorders.
health
Children With Cancer Get More Access to Experimental Drugs
New U.S. law will require pediatric cancer clinic trials.
U.S. Preventive Services Task Force Confronts Critics
In May, the U.S. Preventive Services Task Force recommended against screening for thyroid cancer. After reviewing the available evidence, the task force concluded…
Why the FDA Wants More Control Over Some Lab Tests
The FDA finds that many so-called laboratory-derived tests may actually harm patients.
What’s Behind That Gut Feeling in Your Mind?
The microbiome may yield a new class of psychobiotics for the treatment of anxiety, depression and other mood disorders.
TSCA 2.0: A New Era in Chemical Risk Management
It took 40 years, but Congress finally revised a major environmental law that wasn’t pleasing anyone.